*Other Operating Data Consensus Source: Bloomberg
More on Procter & Gamble
- Procter & Gamble: A Buying Strategy For The Dividend Stock
- Procter & Gamble: The Market Is Wrong – It’s Time To Buy This Compounder (Rating Upgrade)
- Procter & Gamble: A Wide Moat, Solid Business – And Still Not A Buy
- Procter & Gamble falls after warning of challenging consumer and geopolitical environment
- Procter & Gamble Non-GAAP EPS of $1.88 beats by $0.02, revenue of $22.21B misses by $80M